Children
d4T (stavudine, Zerit) is licensed for use in children over three months of age. The recommended dose is 1mg/kg twice daily in children weighing less than 30kg. Children above this weight should take the adult dose[1].
Studies have shown than the incidence of side-effects in children taking d4T is similar to that in adults.
Although unlicensed for use below three months, two studies have demonstrated that d4T-containing combinations are effective in very young infants:
latest aidsmap news
- Large HIV vaccine study will not go ahead
- Swiss court rules all people with HIV can be criminally liable for transmission, even if untested
- Genital shedding of HIV in women with undetectable viral load: less of it, but still happening
- Microbicides could prevent more infections in men than in women
- Knowledge of STIs poor in rural Tanzania - associated with risky sex and infection with HIV
- HIV treatment effective for infants in resource-limited settings
- Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
- One third of people with HIV have experienced sexual difficulties in the past month
- Differing causes of lung infections in HIV-positive patients: implications for diagnosis and treatment
- Roche to halt HIV drug research